ACM
EPIX

Asymmetry Capital Management’s ESSA Pharma EPIX Stock Holding History

Asymmetry Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-212,525
Closed -$6.07M – 35
2021
Q2 		$6.07M Sell
212,525
-71,934
-25% -$2.09M 4.17% 10
2021
Q1 		$8.26M Buy
+284,459
New +$6.61M 4.27% 12

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Asymmetry Capital Management's EPIX Position: Q3 2021 in Review

Asymmetry Capital Management sold out of ESSA Pharma (EPIX) in Q3 2021, closing a stake of 212,525 shares — an estimated $6.07M sold.

Asymmetry Capital Management first reported a position in EPIX in Q1 2021 and held it in 2 quarters. The position peaked at $8.26M in Q1 2021. 75 funds tracked by Wall St. Rank hold EPIX as of Q3 2021.

  • Asymmetry Capital Management reported no remaining ESSA Pharma position as of Q3 2021 after selling out during the quarter.
  • Asymmetry Capital Management sold 212,525 ESSA Pharma shares in Q3 2021, an estimated $6.07M.
  • Asymmetry Capital Management first reported a position in ESSA Pharma in Q1 2021 and held it in 2 quarters.
  • Asymmetry Capital Management's ESSA Pharma position peaked at $8.26M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2021.

Based on Asymmetry Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.